文献速递脑血管病

血管内取栓与药物治疗在孤立性M2闭塞中的比较:EXTEND-IA试验、INSPIRE和SELECT研究的汇总患者水平分析

Endovascular Thrombectomy Versus Medical Management in Isolated M2 Occlusions: Pooled Patient-Level Analysis from the EXTEND-IA Trials, INSPIRE, and SELECT Studies.
PubMed 文献 · Ann Neurol · 2022-03-17

该汇总患者水平分析纳入3项随机对照试验和2项前瞻性非随机研究,共517例孤立性M2闭塞患者,比较血管内取栓与药物治疗。取栓与更高的90天功能独立相关(68.3% vs 61.6%,aOR=2.42),且死亡率更低(5% vs 10%,aOR=0.32),该关联主要见于存在灌注不匹配和卒中较重的患者。

要点

  • 取栓组90天功能独立68.3% vs 药物组61.6%,aOR=2.42,95%CI=1.25-4.67,p=0.008。
  • 取栓组死亡率5% vs 药物组10%,aOR=0.32,95%CI=0.12-0.87,p=0.025。
  • 灌注不匹配患者中取栓功能独立70.7% vs 61.3%,aOR=2.29;无不匹配者两组无差异。

核心结论

  • 在M2闭塞患者中,与药物治疗相比,血管内取栓与改善的临床结局相关。
  • 这种关联主要见于存在灌注不匹配和卒中严重程度较高的患者。

研究设计与样本

  • 汇总患者水平分析,纳入3项随机对照试验(EXTEND-IA、EXTEND-IA-TNK第1和第2部分)和2项前瞻性非随机研究(INSPIRE和SELECT)。
  • 共纳入517例孤立性M2闭塞患者,其中血管内取栓组195例,药物治疗组322例。

主要发现

  • 基线中位NIHSS取栓组为13(IQR 8-19)vs 药物组10(IQR 6-15),p<0.001。
  • 治疗前缺血核心体积取栓组10(0-24)ml vs 药物组9(3-21)ml,p=0.59。
  • 与药物治疗相比,取栓更常与功能独立相关(68.3% vs 61.6%,aOR=2.42,95%CI=1.25-4.67,p=0.008;IPTW-OR=1.75,95%CI=1.00-3.75,p=0.05),并伴有mRS结局改善的偏移(校正cOR=2.02,95%CI=1.23-3.29,p=0.005)。
  • 取栓组死亡率5% vs 药物组10%,aOR=0.32,95%CI=0.12-0.87,p=0.025。
  • 在灌注不匹配患者中,取栓与更高的功能独立相关(70.7% vs 61.3%,aOR=2.29,95%CI=1.09-4.79,p=0.029;IPTW-OR=2.02,95%CI=1.08-3.78,p=0.029);无不匹配者中未发现差异(43.8% vs 62.7%,p=0.17;IPTW-OR=0.71,95%CI=0.18-2.78,p=0.62)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The objective of this study was to evaluate functional and safety outcomes of endovascular thrombectomy (EVT) versus medical management (MM) in patients with M2 occlusion and examine their association with perfusion imaging mismatch and stroke severity. METHODS: In a pooled, patient-level analysis of 3 randomized controlled trials (EXTEND-IA, EXTEND-and IA-TNK parts 1 and 2) and 2 prospective nonrandomized studies (INSPIRE and SELECT), we evaluated EVT association with 90-day functional independence (modified Rankin Scale [mRS] = 0-2) in isolated M2 occlusions as compared to medical management overall and in subgroups by mismatch profile status and stroke severity. RESULTS: We included 517 patients (EVT = 195 and MM = 322), baseline median (interquartile range [IQR]) National Institutes of Health Stroke Scale (NIHSS) was 13 (8-19) in EVT versus 10 (6-15) in MM, p < 0.001. Pretreatment ischemic core did not differ (EVT = 10 [0-24] ml vs MM = 9 [3-21] ml, p = 0.59). Compared to MM, EVT was more frequently associated with functional independence (68.3 vs 61.6%, adjusted odds ratio [aOR] = 2.42, 95% confidence interval [CI] = 1.25-4.67, p = 0.008, inverse probability of treatment weights [IPTW]-OR = 1.75, 95% CI = 1.00-3.75, p = 0.05) with a shift toward better mRS outcomes (adjusted cOR = 2.02, 95% CI:1.23-3.29, p = 0.005), and lower mortality (5 vs 10%, aOR = 0.32, 95% CI = 0.12-0.87, p = 0.025). EVT was associated with higher functional independence in patients with a perfusion mismatch profile (EVT = 70.7% vs MM = 61.3%, aOR = 2.29, 95% CI = 1.09-4.79, p = 0.029, IPTW-OR = 2.02, 1.08-3.78, p = 0.029), whereas no difference was found in those without mismatch (EVT = 43.8% vs MM = 62.7%, p = 0.17, IPTW-OR: 0.71, 95% CI = 0.18-2.78, p = 0.62). Functional independence was more frequent with EVT in patients with moderate or severe strokes, as defined by baseline NIHSS above any thresholds from 6 to 10, whereas there was no difference between groups with milder strokes below these thresholds. INTERPRETATION: In patients with M2 occlusion, EVT was associated with improved clinical outcomes when compared to MM. This association was primarily observed in patients with a mismatch profile and those with higher stroke severity. ANN NEUROL 2022;91:629-639.

来源:Ann Neurol,查看原文。版权归原作者所有。

引用

  1. Sarraj A, Parsons M, Bivard A, et al. Endovascular Thrombectomy Versus Medical Management in Isolated M2 Occlusions: Pooled Patient-Level Analysis from the EXTEND-IA Trials, INSPIRE, and SELECT Studies. Ann Neurol. 2022. PMID: 35184327. doi:10.1002/ana.26331

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。